Homeward
United States
- San Francisco, CA
- 03/08/2022
- Series B
- $50,000,000
A technology-enabled healthcare provider delivering care to those who don’t have it. Starting in rural America.
- Industry Hospital & Health Care
- Website https://homewardhealth.com/
- LinkedIn https://www.linkedin.com/company/homewardhealth/about/
Related People
Jennifer Schneider, M.D., M. S.Founder
United States -
St Helena, California
I am CEO of Homeward, a technology-enabled healthcare provider delivering care to those who don’t have it, starting in rural America.
Previously, I served 5 years as the Chief Medical Officer and President of Livongo. At Livongo, I was responsible for product, data science, engineering, marketing, clinical operations, and our growth strategy. In my final year at Livongo, we led the company through the largest consumer digital health Initial Public Offering in history, a secondary offering, a convertible debt offering that raised over $540 million, and the industry’s largest merger ever between Livongo and Teladoc Health, valuing Livongo at $18.5 billion and beginning a new era of consumer centric virtual care. I was honored by Modern Healthcare as one of the 50 Most Influential Clinical Executives and by Fierce Healthcare as Woman of Influence for our work empowering women and modeling diversity and inclusion in the workplace.
In October of 2020, I joined the Board of the Health Assurance Acquisition Corp., a Special Purpose Acquisition Company (SPAC) with Hemant Taneja, Glen Tullman, Dr. Stephen Klasko, Quentin Clark, and Anita V. Pramoda. Our mission is to partner with leading health and care businesses leveraging technology. We aim to support their efforts to become iconic category winners that accelerate the digital transformation of existing healthcare into a new system of health assurance.
Zero Homes | $16,800,000 | (Feb 19, 2026)
Rainfall Health | $15,000,000 | (Feb 19, 2026)
inKind | $450,000,000 | (Feb 19, 2026)
Sift Biosciences | $3,700,000 | (Feb 19, 2026)
Avantos.ai | $25,000,000 | (Feb 19, 2026)
Korsana Biosciences | $175,000,000 | (Feb 19, 2026)
Vervesemi | $10,000,000 | (Feb 19, 2026)
Efficient Computer | $60,000,000 | (Feb 19, 2026)
DG Matrix | $60,000,000 | (Feb 19, 2026)
Synchrony Medical | $5,000,000 | (Feb 19, 2026)
Dataro | $14,280,000 | (Feb 18, 2026)
The Compression Company | $3,400,000 | (Feb 18, 2026)